Stay updated on UNR844-Cl Eye Drops in Presbyopia: Clinical Trial

Sign up to get notified when there's something new on the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page. This reflects a page-level update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-17T08:38:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s footer “Revision” was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:47:07.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces v3.5.0. No visible changes to the study details on the page.
    Difference
    0.1%
    Check dated 2026-04-18T13:33:39.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.0 and the previous Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T01:08:59.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T19:05:58.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2. No other content appears to be affected.
    Difference
    0.1%
    Check dated 2026-02-13T12:23:11.000Z thumbnail image

Stay in the know with updates to UNR844-Cl Eye Drops in Presbyopia: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page.